189 related articles for article (PubMed ID: 33611087)
1. Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Dirksen CD; Schols JMGA; Wouters EFM; Janssen DJA
Respir Med; 2021 Apr; 179():106330. PubMed ID: 33611087
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
3. Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
Ekström M; Ferreira D; Chang S; Louw S; Johnson MJ; Eckert DJ; Fazekas B; Clark KJ; Agar MR; Currow DC;
JAMA; 2022 Nov; 328(20):2022-2032. PubMed ID: 36413230
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
5. A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.
Currow D; Watts GJ; Johnson M; McDonald CF; Miners JO; Somogyi AA; Denehy L; McCaffrey N; Eckert DJ; McCloud P; Louw S; Lam L; Greene A; Fazekas B; Clark KC; Fong K; Agar MR; Joshi R; Kilbreath S; Ferreira D; Ekström M;
BMJ Open; 2017 Jul; 7(7):e018100. PubMed ID: 28716797
[TBL] [Abstract][Full Text] [Related]
6. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
7. The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial.
Farquhar MC; Prevost AT; McCrone P; Brafman-Price B; Bentley A; Higginson IJ; Todd CJ; Booth S
Trials; 2016 Apr; 17():185. PubMed ID: 27044249
[TBL] [Abstract][Full Text] [Related]
8. Patients' and their caregivers' experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study.
Ferreira D; Kochovska S; Honson A; Phillips J; Currow D
BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35606022
[TBL] [Abstract][Full Text] [Related]
9. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study.
Martins RT; Currow DC; Abernethy AP; Johnson MJ; Toson B; Eckert DJ
Respirology; 2016 Feb; 21(2):386-91. PubMed ID: 26560987
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).
Cross J; Elender F; Barton G; Clark A; Shepstone L; Blyth A; Bachmann M; Harvey I;
Health Technol Assess; 2010 May; 14(23):1-147, iii-iv. PubMed ID: 20487638
[TBL] [Abstract][Full Text] [Related]
12. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
Currow D; Louw S; McCloud P; Fazekas B; Plummer J; McDonald CF; Agar M; Clark K; McCaffrey N; Ekström MP;
Thorax; 2020 Jan; 75(1):50-56. PubMed ID: 31558624
[TBL] [Abstract][Full Text] [Related]
13. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective.
Schroeder M; Benjamin N; Atienza L; Biswas C; Martin A; Whalen JD; Izquierdo Alonso JL; Riesco Miranda JA; Soler-Cataluña JJ; Huerta A; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():1621-1632. PubMed ID: 32764908
[TBL] [Abstract][Full Text] [Related]
15. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.
Johnson MJ; Cockayne S; Currow DC; Bell K; Hicks K; Fairhurst C; Gabe R; Torgerson D; Jefferson L; Oxberry S; Ghosh J; Hogg KJ; Murphy J; Allgar V; Cleland JGF; Clark AL
ESC Heart Fail; 2019 Dec; 6(6):1149-1160. PubMed ID: 31389157
[TBL] [Abstract][Full Text] [Related]
16. Morphine for chronic breathlessness in COPD: improvement predictors-cross-sectional study.
Verberkt CA; van den Beuken-Everdingen MHJ; Schols JMGA; Wouters EFM; Janssen DJA
BMJ Support Palliat Care; 2024 Jan; 13(e3):e829-e832. PubMed ID: 35850961
[TBL] [Abstract][Full Text] [Related]
17. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
18. The impact of regular, low-dose, sustained-release morphine for chronic breathlessness on caregiver burden: An exploratory analysis of the BEAMS trial.
Kochovska S; Ferreira D; Chang S; Luckett T; Roydhouse J; Ekström M; Currow DC
Palliat Med; 2024 Jan; 38(1):156-162. PubMed ID: 37978419
[TBL] [Abstract][Full Text] [Related]
19. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.
Poole PJ; Veale AG; Black PN
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1877-80. PubMed ID: 9620921
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness and cost-utility of a Web-based or print-delivered tailored intervention to promote physical activity among adults aged over fifty: an economic evaluation of the Active Plus intervention.
Golsteijn RH; Peels DA; Evers SM; Bolman C; Mudde AN; de Vries H; Lechner L
Int J Behav Nutr Phys Act; 2014 Sep; 11():122. PubMed ID: 25262435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
